Clinical Trial Update: Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF [Phase 4]

View source ↗

Summary

This Phase 4 trial update evaluates a protocol for reducing anti-TNF dosing in patients with spondyloarthropathies who are in clinical remission, to assess whet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spondyloarthropathies

Snippet

Sponsor: Spanish Clinical Pharmacology Society | Conditions: Spondylarthropathies | Phase 4 | Status: COMPLETED